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Patched 1 and Patched 2 Redundancy Has a Key Role
in Regulating Epidermal Differentiation
Christelle Adolphe1,5, Erica Nieuwenhuis2,5, Rehan Villani1,5, Zhu Juan Li2,3, Pritinder Kaur4, Chi-chung Hui2,3
and Brandon J. Wainwright1
The Patched 1 (Ptch1) receptor has a pivotal role in inhibiting the activity of the Hedgehog (Hh) pathway and is
therefore critical in preventing the onset of many human developmental disorders and tumor formation.
However, the functional role of the mammalian Ptch2 paralogue remains elusive, particularly the extent to which
it contributes to regulating the spatial and temporal activity of Hh signaling. Here we demonstrate in three
independent mouse models of epidermal development that in vivo ablation of both Ptch receptors results in a
more severe phenotype than loss of Ptch1 alone. Our studies indicate that concomitant loss of Ptch1 and Ptch2
activity inhibits epidermal lineage specification and differentiation. These results reveal that repression of Hh
signaling through a dynamic Ptch regulatory network is a crucial event in lineage fate determination in the skin.
In general, our findings implicate Ptch receptor redundancy as a key issue in elucidating the cellular origin of
Hh-induced tumors.
Journal of Investigative Dermatology (2014) 134, 1981–1990; doi:10.1038/jid.2014.63; published online 27 February 2014
INTRODUCTION
The Hedgehog (Hh) signaling pathway has a central role in
regulating appropriate embryonic development and maintain-
ing adult tissue homeostasis. Disruption to the spatiotemporal
activation of the Hh pathway can lead to a number of deve-
lopmental defects, including craniofacial, limb, and skeletal
anomalies, whereas persistent pathway activity is linked to the
formation of various cancers, the most common being basal
cell carcinoma (BCC) of the skin and medulloblastoma of
the cerebellum (Adolphe et al., 2006; Yang et al., 2008b).
In the absence of Hh ligand, the Patched 1 (Ptch1) protein
functions to maintain the Hh pathway in an inactive state by
inhibiting translocation of the signaling effector Smoothened
(Smo) to the primary cilium (Rohatgi et al., 2007; Ingham
et al., 2011). Hh ligands activate pathway signaling in target
cells by binding to the Ptch1 receptor and stimulating
internalization and lysosomal degradation of the Hh–Ptch1
complex (Mastronardi et al., 2000), thus relieving the repres-
sive effect on Smo. Activated Smo subsequently translocates to
the primary cilium (Rohatgi et al., 2007; Ingham et al., 2011),
where it activates Gli transcription factors to enter the nucleus
and initiate transcription of target genes, among them Ptch1
itself.
Various components of the Hh pathway have been manipu-
lated in the epidermis of murine skin, resulting in pathway
activation and the subsequent formation of epidermal lesions
reminiscent of human BCCs (Oro et al., 1997; Xie et al., 1998;
Grachtchouk et al., 2000; Adolphe et al., 2004; Youssef et al.,
2010; Grachtchouk et al., 2011; Kasper et al., 2011; Wang
et al., 2011; Wong and Reiter, 2011). In such murine models,
BCC formation often occurs at the expense of hair follicles
(HFs), suggesting that pathway activity diverts follicular cells
toward a tumorigenic fate. The Hh pathway activation in the
skin also results in hyperproliferation of the epidermal basal
cell compartment, where the transient amplifying progenitor
cell population resides, and in a subsequent delay in the onset
of interfollicular epidermis (IFE) differentiation (Adolphe et al.,
2004; Adolphe et al., 2006; Villani et al., 2010). The endo-
genous Hh pathway activity in the skin is essential for the
downgrowth of HFs during both embryonic development (St-
Jacques et al., 1998; Chiang et al., 1999) and the adult HF
cycle (Sato et al., 1999; Wang et al., 2000). The appropriate
spatiotemporal activation of the Hh pathway is achieved by a
complex network of positive and negative regulators acting at
various tiers of the pathway (Ingham et al., 2011), in which
Ptch has a paramount role.
Ptch1 encodes a 12-pass transmembrane glycoprotein that
exhibits dual regulatory activities. Not only does Ptch1
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function to maintain Smo in an inactive state, but transcrip-
tional activation of Ptch1 as a Hh target gene also functions as
a critical negative feedback regulatory loop, which serves to
attenuate pathway activity through sequestration of Hh ligand
(Chen and Struhl, 1996). Although Ptch1 is the most exten-
sively studied Hh receptor, there exists another important yet
rarely acknowledged receptor, Patched 2 (Ptch2). This second
mammalian Ptch paralogue shares a significant degree of
sequence and structural homology with Ptch1 (Motoyama
et al., 1998). Both Ptch receptors have been shown to exhibit
Hh ligand–binding activity, and there is evidence to suggest
that both receptors can interact with Smo (Carpenter et al.,
1998). Similar to Ptch1, transcriptional activation of Ptch2
occurs in response to Shh (Takabatake et al., 1997), is
downregulated in the absence of Gli (Motoyama et al.,
1998), and its expression is high in both human BCC and
medulloblastoma (Zaphiropoulos et al., 1999; Lee et al.,
2006). In addition, analyses of zebrafish ptc1;ptc2 double
mutants have indicated an increase in the level of Hh target
gene activation upon loss of both receptors (Koudijs et al.,
2008; Hammond et al., 2010). However, unlike the broad
developmental defects and early embryonic lethality
associated with loss of Ptch1 activity in murine embryonic
development (Goodrich et al., 1997), we have previously
demonstrated that the sole defect observed in Ptch2-deficient
mice is a loss of HF structures and epidermal hyperplasia
in aged male mice (Nieuwenhuis et al., 2006). These data
suggest that mammalian Ptch2 has a functional role in the
skin. Although the skin phenotype of Ptch2-deficient mice is
subtle, it is possible that Ptch2 activity is obscured due to the
persistence of Ptch1-receptor activity. Despite evidence to
suggest that Ptch2 is a downstream target of the Hh pathway
and contributes to its negative regulation, the degree of
functional compensation and/or redundancy between the
two Ptch receptors remains uncharacterized.
In order to investigate the degree of functional redundancy
between the two Ptch receptors, we concurrently ablated both
Ptch1 and Ptch2 activity in the basal cells of adult and
embryonic mouse epidermis using three distinct Cre-recombi-
nase transgenes. Here, we show that, for each mouse model
described, the phenotype of Ptch1;Ptch2-deficient epidermis is
distinct from the loss of Ptch1 alone. Surprisingly, we show
that combined loss of Ptch receptor activity in developing
epidermal keratinocytes results in a previously undescribed
phenotype, namely, complete inhibition of HF, sebaceous
gland (SG), and IFE lineage specification as well as differentia-
tion. Collectively, this study shows that Ptch2 functions in
collaboration with Ptch1 in regulating Hh signal transduction
in the epidermis and that Ptch receptor activity is required for
keratinocytes to respond to lineage specification and differ-
entiation signals.
RESULTS
The Hh pathway activity in the epidermis uses both Ptch1 and
Ptch2 as negative feedback regulators
In order to gain an understanding of the functional relationship
between Ptch1 and Ptch2 in the skin, we set out to identify
which epidermal cell populations exhibit endogenous Ptch1
and/or Ptch2 activity. Immunohistochemical detection of
b-galactosidase expression of E18.5 Ptch1lacZ/þ (Goodrich
et al., 1997) skin revealed that Ptch1 is strongly expressed in
the dermal papillae of developing HFs and in a small number
of follicular and IFE keratinocytes (Supplementary Figure S1a
online, arrows). We also observe the evidence of weak Ptch1
expression in cells spanning the length of the developing HF
and in a subset of basal cells within the IFE (Supplementary
Figure S1a online). Although previous studies have published
a more restricted expression profile via X-gal detection, Ptch1
expression in a broad population of IFE and HF basal cells is
consistent with our previous publication data (Adolphe et al.,
2006). In order to detect the endogenous expression of Ptch2
by analogous means, we generated a Ptch2lacZ/þ reporter
mouse (Supplementary Figure S2 online). Immunohistochemical
detection of b-galactosidase expression of E18.5 Ptch2lacZ/þ skin
revealed that Ptch2 is likewise expressed throughout the HF
but not in the IFE (Supplementary Figure S1b online, asterisks),
indicating that there is an overlap in the expression of both
Ptch1 and Ptch2. On the basis of their expression patterns in
the developing epidermis, both Ptch1 and Ptch2 may function
in regulating the activity of the Hh pathway in cells of the
developing HF.
To examine functional overlap between the two Ptch
receptors, we determined whether the loss of one Ptch
receptor activity resulted in transcriptional activation of
the other Ptch paralogue. As previously published, E18.5
Ptch2tm1/tm1 embryos are wild type in appearance with no
evidence of aberrant Hh pathway activity (as represented by
Gli1 transcriptional activation) in the developing epidermis
(Supplementary Figure S1g online). We propose that this is
likely due to sustained negative regulation of the pathway as a
result of ectopic Ptch1 transcription in the IFE of Ptch2-defi-
cient skin (Supplementary Figure S1j online) (Nieuwenhuis
et al., 2006). By contrast, we show that following loss of Ptch1
in the developing epidermis of K5Cre:Ptch1lox/loxmice, clear
embryonic epidermal defects arise, and E18.5 skin exhibits
pathway activation through upregulation of the canonical Hh
target genes Gli1 and Ptch1 (Supplementary Figure S1h online
and data not shown). Consistent with the transcriptional
activation of Ptch1 in Ptch2-deficient skin, we observed
ectopic transcriptional activation of Ptch2 in Ptch1-deleted
skin (Supplementary Figure S1k online). These data further
support the contention that Ptch2 is a target of the Hh pathway
activity and suggest that functional compensation between
Ptch1 and Ptch2 receptor activity in the skin may be in
operation. It is important to note that ectopic Hh pathway
activation is observed in Ptch1-deficient mice despite tran-
scriptional activation of Ptch2, indicating that Ptch2 is unable
to functionally compensate for the loss of the Ptch1 pathway
repression.
Concomitant loss of Ptch1 and Ptch2 accelerates the onset of
Ptch1-derived skin lesions
As one approach to address whether Ptch1 and Ptch2 exhibit
overlapping activity in the skin, we followed a similar
approach to that taken by Lee et al. (2006), which describes
an increase in medulloblastoma incidence upon loss of both
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Ptch1 and Ptch2 activity. In order to specifically induce Ptch1
ablation in adult skin, we took advantage of the tamoxifen
(TM)-inducible K14CreERT2 model. No overt phenotype was
observed in vehicle-treated skin (Supplementary Figure S3a
and b online) or in TM treatment of control epidermis (data not
shown). Consistent with the preliminary stages of skin tumor-
igenesis generated by loss of Ptch1, 4 weeks after TM
treatment, K14CreERT2:Ptch1lox/lox mice presented with mild
epidermal hyperplasia and intermittent regions in which basal
cells began to invade the dermis (Supplementary Figure S3c
online: arrows). By contrast, the neoplastic transformation of
K14CreERT2:Ptch1lox/lox;Ptch2tm1/tm1 TM-treated skin was
more advanced, with features reminiscent of early BCC
formation. Four weeks after TM treatment of K14CreERT2:Pt-
ch1lox/lox;Ptch2tm1/tm1mice, we observed epidermal nests ori-
ginating from both the IFE and HF structures that had markedly
invaded the dermis, with the characteristic BCC feature of
cells palisading the periphery of the invading mass
(Supplementary Figure S3d online: asterisk). Given that pro-
gression toward a BCC-like phenotype was more advanced in
K14CreERT2:Ptch1lox/lox;Ptch2tm1/tm1 adult skin, these data
provide in vivo evidence to indicate an overlap in the activity
of both Ptch1 and Ptch2 in restraining the tumor-inducing
signals of the Hh pathway in epidermal tissue.
Embryonic HF lineage differentiation requires Ptch receptor
activity
After having established a likely functional role for Ptch2 in
adult epidermis, we addressed whether Ptch2 biological
activity is restricted to adult epidermis or whether it also
functions in regulating embryonic development of the skin.
We have previously observed that conditional ablation of
Ptch1 using a K14Cre transgene, moderately active from E15.0
in embryonic epidermis (Supplementary Figure S4a online),
results in viable fertile mice (Villani et al., 2010). More
specifically, the embryonic epidermis of E18.5 K14Cre:
Ptch1lox/lox mice is indistinguishable from that of Ptch2tm1/tm1
and control mice. Histologically, control, Ptch2tm1/tm1, and
K14Cre:Ptch1lox/lox epidermis all present with the appropriate
density of developing HFs and a fully stratified IFE (Figure 1a–c).
The typical distribution of a single basal cell layer (keratin 14,
K14, Figure 1e–g), and successive squamous (K10, Figure
1i–k) and cornified (loricrin, data not shown) layers, confirms
the normal differentiation and stratification of the IFE in the
absence of either Ptch1 or Ptch2 alone. Together, these results
indicate that in the presence of either Ptch1 or Ptch2 receptor
activity, embryonic HF morphogenesis and IFE stratification
are unaffected.
We next assessed whether the loss of both Ptch1 and Ptch2
receptor activity would perturb the development of embryonic
epidermis. Concomitant ablation of both Ptch1 and Ptch2
activity (K14Cre:Ptch1lox/lox;Ptch2tm1/tm1) resulted in perinatal
lethality, which was clearly distinct from unaffected, viable
K14Cre:Ptch1lox/lox or Ptch2tm1/tm1 mice. The most obvious
histological defect in E18.5 K14Cre:Ptch1lox/lox;Ptch2tm1/tm1
epidermis was the presence of hyperplastic epidermal invagi-
nations (Figure 1d, arrows). IFE stratification appeared grossly
normal via histology and standard IFE differentiation marker
analyses (K14, K10, or Loricrin) (Figure 1d, h, and l). In order
to characterize the follicular nature of the mutant invaginating
structures, we screened a cohort of HF lineage markers and
observed these cells to express p-cadherin (Figure 2b), a
marker of HF induction. We also observed the expression of
CDP (Figure 2d) and Sox9 (Figure 2f), markers of an early hair
germ stage of follicular development. In wild-type epidermis,
cells undergoing HF morphogenesis (specifically those pene-
trating down into the dermis) express the transcription factor
Lef1, marking acquisition of a HF multi-potent progenitor
(matrix) cell fate committed to terminally differentiating
along the hair shaft lineage (Figure 2g: arrows). In contrast,
K14Cre:Ptch1lox/lox;Ptch2tm1/tm1-deficient keratinocyteswithin
the mutant follicular-like structures failed to express Lef1
(Figure 2h: asterisks). Nor did these structures express other
HF lineage markers, including AE15 and AE13 (data not
shown). Furthermore, we show that K14Cre:Ptch1;Ptch2 adult
skin grafts (9 weeks) develop BCC with complete absence of
mature HF structures (Figure 2j). These data further support the
fact that, despite HF lineage initiation, K14Cre:Ptch1;Ptch2
null cells do not proceed along the HF and hair shaft
differentiation program. Consistent with being maintained in
an early primitive HF cell fate, K14Cre:Ptch1lox/lox;Ptch2tm1/tm1
epidermal invaginations continue to express markers charac-
teristic of the G1/S phase of the cell cycle (cyclin D1)
(Figure 1p) and proliferation (proliferating cell nuclear antigen
(PCNA)) (Figure 1n). In order to address the HF-restricted
phenotype of K14Cre:Ptch1lox/lox;Ptch2tm1/tm1 epidermis, we
performed detailed analyses of the spatial and temporal acti-
vity of the K14Cre transgene using both K14Cre:ROSAlacZ/þ
and K14Cre:ROSAEYFP/þ models. These data revealed that
Cre-mediated deletion (lacZ- positive cells) was predomi-
nately localized within the HF structures, with only intermittent
recombined interfollicular keratinocytes (Supplementary
Figure S4a and c online). To further confirm the follicular-
restricted activity of K14Cre, we screened for the distribution
of the Hh pathway activity in K14Cre:Ptch1lox/lox;Ptch2tm1/tm1
epidermis and observed high levels of Gli1 target gene
transcription in the mutant follicular-like structures
(Supplementary Figure S4e online), with no evidence of IFE
Hh pathway activity.
These data suggest that, in the absence of any Ptch receptor
activity in developing HFs, follicular cells become unrespon-
sive to the HF differentiation program and are instead main-
tained in an actively proliferating state. Furthermore, these
data indicate that Ptch receptor activity is necessary for HF
lineage morphogenesis, such that basal keratinocytes require
the functional activity of either Ptch1 or Ptch2 for HF lineage
specification and differentiation.
Ptch receptor activity is required by epidermal keratinocytes for
epidermal lineage specification and differentiation to occur
After having established Ptch-deficiency results in complete
loss of embryonic HF cell fate, we next addressed whether
Ptch receptor activity is required for IFE lineage differentiation.
For this approach, we used another well-characterized
embryonic skin model, K5Cre (Tarutani et al., 1997).
Analyses of K5Cre:ROSAlacZ/þ and K5Cre:ROSAEYFP/þ
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reporter mice revealed intense b-galactosidase and EYFP
staining in the vast majority of epidermal basal keratinocytes
and developing HF cells from E15.0 (Supplementary Figure
S4b and d online) compared with the predominately follicular-
like activity of K14Cre described above. Wide-ranging K5Cre
activity is further supported by evidence of the pathway in all
epidermal cells of K5Cre:Ptch1;Ptch2 skin (Supplementary
Figure S4f online), with respect to follicular-restricted activity
in K14Cre: Ptch1;Ptch2 epidermis (Supplementary Figure S4e
online). Consistent with widespread gene deletion by the
K5Cre transgene during embryonic epidermal development,
we observed perinatal lethality upon inactivation of Ptch1
alone (K5Cre:Ptch1lox/lox), and the E18.5 epidermis revealed
perturbed HFs (Figure 3d) alongside modest K14 basal cell
hyperproliferation (Figure 4w) and delayed onset of IFE
differentiation (Figure 4g and j). K5Cre:Ptch1lox/lox embryos
thus faithfully model the mitogenic effects commonly attrib-
uted to the Hh pathway activation during embryonic devel-
opment. This embryonic phenotype is clearly distinct from the
normal development observed in K14Cre:Ptch1lox/lox epider-
mis, as described above.
We next asked whether loss of both Ptch1 and Ptch2 would
amplify the severity of this mitogenic phenotype, potentially
shedding light on the functional role of Ptch2 during embryo-
nic epidermal development. K5Cre:Ptch1lox/lox;Ptch2tm1/tm1
embryos are readily distinguishable upon embryonic dissec-
tion as they exhibit a taut and highly transparent epidermis
(Figure 3a) with no evidence of HF protrusions (Figure 4a).
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Figure 1. K14Cre:Patched-deficient skin is maintained in a hyperproliferative state. (a–d) Histology of E18.5 transgenic epidermis. Note loss of typical elongated
follicular structures in K14Cre:Ptch1lox/lox; Ptch2tm1/tm1 invaginations (d: arrows). (e–h) Basal (K14), (i–l) suprabasal (K10), and (m, n) cornified (loricrin) cell
layers present in E18.5 transgenic skin. Expanded PCNA (proliferating cell nuclear antigen; n) and maintained expression of (p: arrows) cycling D1 in
K14Cre:Ptch1lox/lox;Ptch2tm1/tm1 invaginations compared with (m: arrows and o) K14Cre:Ptch1lox/lox control skin. bcl: basal cell layer, cl: cornified layer;
sbl: suprabasal cell layer. Bar¼ 50mm.
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Histologically, E18.5 K5Cre:Ptch1lox/lox;Ptch2tm1/tm1 epidermis
presented as a hyperplastic mass of invaginating interfollicular
keratinocytes, which lacked any HF or SG structures
(Figure 4e). Unlike the primordial HF fate attributed to
K14Cre:Ptch1lox/lox;Ptch2tm1/tm1 -deficient keratinocytes, we
observed no evidence of Sox9, CDP, or nuclear b-Catenin
expression in K5Cre:Ptch1lox/lox;Ptch2tm1/tm1 epidermis
(Supplementary Figure S5 online). Moreover, there was no
evidence of p-cadherin expression (Supplementary Figure S5
online). These data support a complete loss of follicular
induction and differentiation in K5Cre:Ptch1lox/lox;Ptch2tm1/tm1
epidermis. Most unexpectedly, however, K5Cre:Ptch1lox/lox;
Ptch2tm1/tm1 epidermis also presented with an apparent loss of
IFE differentiation (Figure 3e). Subsequent immunostaining
analyses confirmed a complete absence of terminally differ-
entiated squamous (K10) and cornified (loricrin) layers
(Figure 3h and k, arrows). Consistent with a loss of IFE differ-
entiation, K5Cre:Ptch1lox/lox;Ptch2tm1/tm1 epidermis exhibits a
complete lack of epidermal barrier function (Figure 4b). This
epidermal barrier defect is restricted to K5Cre:Ptch1lox/lox;
Ptch2tm1/tm1 epidermis and is not evident in all other mouse
models described herein (K14Cre:Ptch1, K14Cre:Ptch1;Ptch2,
and K5Cre:Ptch1). Although epidermal barrier defects have
been identified in a number of epidermal mouse models, such
defects have been predominantly attributed to delays in IFE
differentiation and/or cell adhesion defects. That K5Cre:
Ptch1lox/lox;Ptch2tm1/tm1 embryos fail to exhibit any degree of
IFE lineage specification of differentiation is an unprecedented
mouse model phenotype.
Consistent with a lack in epidermal lineage differentiation,
K5Cre:Ptch1lox/lox;Ptch2tm1/tm1 keratinocytes fail to exit the
proliferating basal cell compartment, maintaining the expres-
sion of proliferative (PCNA, Ki67, CyclinD1) (Figure 4c, f,
and i) and progenitor-like markers (p63/K17/K15) (Figure 4o, r,
and u). However, it is interesting to note that, although
undifferentiated and actively proliferating, the K5Cre:Pt-
ch1lox/lox;Ptch2tm1/tm1 keratinocytes express relatively low
levels of the keratins typically present in resident basal cells
(K5 and K14) (Figure 4i and x). In summary, these data
demonstrate that loss of both Ptch1 and Ptch2 receptor activity
in developing epidermal keratinocytes results in a complete
lack of HF and SG lineage fate specification, and, strikingly, a
complete absence of IFE stratification and differentiation. This
is a previously unreported mouse model phenotype presenting
with total inhibition of IFE stratification and clearly illustrates
that either Ptch1 or Ptch2 receptor activity is essential for
keratinocytes to initiate and commit to differentiate along all
epidermal lineages.
DISCUSSION
Here we show that Ptch1 and Ptch2 exhibit a partial overlap
in function. Importantly, a pivotal role for Ptch receptor
activity in epidermal morphogenesis has been revealed. This
study furthers our understanding of the functional relationship
between the two mammalian Ptch receptors in several ways. It
demonstrates that Ptch1 and Ptch2 are paralogous genes that
do not appear to have undergone complete functional diver-
gence, but rather both can act to negatively regulate the Hh
pathway activity in the skin. More precisely, Ptch1 and Ptch2
can partially compensate for each other but are not function-
ally redundant. Our results also reveal that the degree of
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Figure 2. K14Cre:Patched-deficient follicular structures exhibit a primordial
hair follicle (HF)–like state. Hair germ stages of follicular development
in control epidermis express (a) p-cadherin, (c) CDP, and (e) Sox9.
K14Cre:Ptch1lox/lox;Ptch2tm1/tm1 invaginations also express (b) p-cadherin,
(d) CDP, and (f) Sox9. A proportion of K14Cre:Ptch1lox/lox;Ptch2tm1/tm1
invaginations did not express CDP (d: asterisks). (g: yellow arrows) Lef1
expression in the HF downgrowths of E18.5 control epidermis. (h: asterisks)
Mutant follicular-like structures invading the dermis fail to express Lef1. (i) HF
structures present in control skin grafts (9 weeks). (j) Presence of basal cell
carcinoma (BCC) lesions and lack of HF structures in K14Cre:Ptch1lox/
lox;Ptch2tm1/tm1 skin grafts. Dermal papillae structures associated with control
HFs (white arrows: a, c, and e) are absent in mutant epidermis. Bar¼ 50mm.
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pathway activity that occurs in the absence of Ptch receptor
repression and attenuation blocks the process of keratinocyte
cell fate determination. This finding highlights the importance
of intact Ptch repression in model systems aimed at elucidat-
ing the molecular clues involved in epidermal lineage cell fate
determination.
Ptch2 has a significant role in regulating skin morphogenesis
Here we describe the epidermal phenotype of three distinct
Ptch1-deficient mouse model systems, which exhibit pheno-
types consistent with previous reports of epidermal hyperpla-
sia and skin neoplasia formation (Adolphe et al., 2006; Villani
et al., 2010). Importantly, we show that loss of both Ptch1 and
Ptch2 activity results in a more severe epidermal phenotype
than loss of Ptch1 alone, providing direct evidence that Ptch2
has an important role in the skin. Our previous study showed
that Ptch2 is not essential for embryonic development and
suggested that Ptch1 might functionally compensate for the
loss of Ptch2, thus potentially masking Ptch2 receptor activity
(Nieuwenhuis et al., 2006). Indeed, we establish here that the
activity of Ptch2 can only be revealed in the absence of Ptch1.
Our data also support the hypothesis that the transcriptional
activation of Ptch2 upon Ptch1 ablation in the epidermis
occurs potentially as a compensatory mechanism, whereby
Ptch1-deficient cells sense disequilibrium in negative
feedback inhibition and thereby recruit the functional
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Figure 3. Loss of glandular, follicular, and interfollicular epidermal lineage specification and differentiation in K5Cre:Patched-deficient skin. Gross morphology
indicating epidermal transparency of (a: LHS and a’) control and (a: RHS and a’’) K5Cre:Ptch1lox/lox;Ptch2tm1/tm1 E18.5 embryos. Epidermal barrier assay
revealing penetration of dye in (b) K5Cre:Ptch1lox/lox;Ptch2tm1/tm1 epidermis. (d) Histology of E18.5 transgenic epidermis revealing perturbed hair follicles (hf) in
K5Cre:Ptch1lox/lox epidermis and (e: arrows) loss of all epidermal appendages and hyperplastic epithelial invaginations in K5Cre:Ptch1lox/lox;Ptch2tm1/tm1 epidermis
compared with (c) controls. Immunohistochemical staining of interfollicular differentiation markers (f–h) K10 and (i–k) loricrin revealing absence of suprabasal (sbl)
(h: arrows) and (k: arrows) cornified cell layers (cl) in K5Cre:Ptch1lox/lox;Ptch2tm1/tm1 epidermis. Bar¼ 50mm.
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activity of Ptch2. Our three epidermal mouse model systems,
described here, clearly showed that Ptch2 has a functional
role in Ptch1-deficient epidermis, which is contrary to
previous in vitro studies, suggesting that the upregulation of
Ptch2 in Ptch1-deficient cells is not indicative of functional
compensation (Bailey et al., 2002). It is therefore possible that
a role for Ptch2 in regulating the morphogenesis and
differentiation of a broader range of mammalian tissues may
become apparent following the generation of other tissue-
specific Ptch1;Ptch2 null models.
Ptch1 and Ptch2 are not functionally equivalent
Our data clearly show that Ptch2 does not exhibit complete
redundancy with Ptch1, but rather that Ptch1 and Ptch2
overlap in their ability to repress the Hh pathway activity,
and Ptch1 appears to have the predominant role. In our initial
characterization of Ptch2, we found that Ptch2 is co-expressed
with Shh in the follicular keratinocytes of developing epider-
mal structures, whereas Ptch1 is highly expressed in comple-
mentary structures (namely the mesenchymal-derived dermal
papillae) (Motoyama et al., 1998). These observations
suggested that Ptch2 might have acquired a function distinct
from that of Ptch1 during epidermal development. On the
other hand, high Ptch2 expression was observed in the testis
(Carpenter et al., 1998) and peripheral nerve cells (Rahnama
et al., 2004; Bajestan et al., 2006), leading to the hypothesis
that Ptch proteins might have undergone functional diver-
gence (more specifically, specialization), whereby each
paralogue exerts Ptch activity in specific tissues. Contrary to
this notion, the genetic studies presented here indicate that
Ptch1 and Ptch2 likely function as degenerate components,
whereby they compensate for one another under certain
conditions. A partial overlap in Ptch receptor activity has
also been suggested in other vertebrate species, such as during
zebrafish ear and somite development. (Koudijs et al., 2008;
Hammond et al., 2010).
The data we present herein show that Ptch2 has a crucial
role in attenuating pathway function following reduced Ptch1
receptor activity in the skin. The signaling activity of the Hh
pathway in Ptch1;Ptch2-deficient keratinocytes results in loss
of a protective IFE barrier and is incompatible with survival. It
is therefore likely that the Ptch gene duplication event arose as
an evolutionary measure to provide robustness to the recep-
tion and attenuation of the Hh signal. This is analogous to an
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already established evolutionary mechanism referred to as
mutational robustness, which represents the ability of an
organism to withstand mutations (Wagner, 2008). That Ptch1
is frequently mutated in epidermal tissue yielding high
incidence of human skin cancer (BCC) supports the evolu-
tion of Ptch2 in preventing lethal adverse effects of Hh
signaling and promoting fitness of an organism.
One possible mechanism by which Ptch2 may exert its
crucial role as a Hh pathway regulator is via increased protein
stability. Previous studies have identified a conserved sequence
present in the cytoplasmic C-terminal domain of Ptch1 pro-
teins that contributes to rapid protein turnover (Lu et al., 2006;
Kawamura et al., 2008). One of the main topological differ-
ences between mammalian Ptch paralogues is that Ptch2
proteins exhibit a truncated C-terminal domain that lacks the
protein turnover regulatory sequence, thus rendering Ptch2
more stable (Kawamura et al., 2008). In light of the data shown
here, it is possible that Ptch2 protein stability could ensure a
more durable effect in limiting the spatial and temporal signal-
ing activity of the pathway and that Ptch2 might function in the
reinforcement of the Hh pathway attenuation.
Inhibition of pathway activity is required for epidermal lineage
specification and differentiation
Dissecting the relationship between the Hh pathway activity
and epidermal development/BCC formation has been
addressed by targeting various tiers of the pathway, including
but not limited to: loss of Ptch1 receptor activity (Adolphe
et al., 2006; Villani et al., 2010; Wang et al., 2011);
overexpression or inhibition of Shh ligand (Fan et al., 1997;
Adolphe et al., 2004) (St-Jacques et al., 1998; Chiang et al.,
1999); constitutive activation or ablation of Smo signaling (Xie
et al., 1998; Grachtchouk et al., 2003; Youssef et al., 2010;
Wong and Reiter, 2011) (Gritli-Linde et al., 2007); and
overexpression of the downstream transcription factors Gli1
and Gli2 (Dahmane et al., 1997) (Grachtchouk et al., 2000;
Sheng et al., 2002).
Here we show that restricted loss of Ptch1 and Ptch2 in the
developing HFs (K14Cre:Ptch1lox/lox;Ptch2tm1/tm1) leads to a
block in the HF differentiation. More specifically,
K14:Ptch1;Ptch2-deficient follicular cells arrest in the early
stages of HF development and are devoid of committed hair
shaft progenitors and a recognizable dermal papillae structure,
both required for later stages of HF differentiation. Our data
therefore show that high levels of constitutive pathway
activation in developing HFs acts to maintain developing HF
cells in a highly proliferative primordial HF-like cell fate.
These data are consistent with previous studies indicating that
overexpression of SmoM2 in K5 or K14 epithelia faithfully
recapitulates a primordial HF-like fate (Yang et al., 2008a;
Youssef et al., 2012).
We also show that developing basal keratinocytes that are
deficient in both Ptch1 and Ptch2 activity (K5Cre:Ptch1lox/lox;
Ptch2tm1/tm1) fail to undergo any evidence of epidermal
lineage commitment. K5Cre;Ptch-deficient keratinocytes
express all the features of proliferating progenitor cell activity
while exhibiting no structural or protein markers of HF, SG, or
IFE lineages, thus leaving the skin devoid of an IFE barrier and
rendering the skin dysfunctional. This study therefore defines
the importance of having at least one functional Ptch receptor
during epidermal development to ensure IFE stratification and
barrier viability.
The role of Ptch receptors in regulating BCC development
Previous studies have shown that BCC development does not
occur in mouse models exhibiting low levels of pathway
activation, such as overexpressing SmoM2 using a truncated
K5 promoter (Grachtchouk et al., 2003), low-level expression
of GLI2DN (Grachtchouk et al., 2011), and a proportion of K5-
Gli1 overexpression mice (Nilsson et al., 2000). BCC develop-
ment is only seen to arise in mouse models exhibiting high
levels of the Hh pathway activation, such as K5-Gli2
(Grachtchouk et al., 2000), K14Cre:SmoM2, K14CreER:
SmoM2 (Youssef et al., 2012), and high-level expression of
GLI2DN (Grachtchouk et al., 2011). Here we show that adult
K14Cre:Ptch1;Ptch2 skin grafts develop BCC lesions. These
data support the fact that loss of both Ptch1 and Ptch2 mimics
a similar level of pathway activation as achieved following
high-level expression of Gli and mutant Smo. However, it is
important to note that the levels of pathway activity induced in
both K14Cre:Ptch1 (Villani et al., 2010) and K14Cre:
Ptch1;Ptch2 models are sufficient to induce BCC formation.
Taken together, these data suggest that the level of pathway
activity achieved upon loss of Ptch1 alone, loss of Ptch1 and
Ptch2, and overexpression of SmoM2 or GLI2DN in K5/K14
models all drive BCC development. Our data lend support to
the proposed model that high levels of Hh signaling activity
are required to yield a BCC tumor–initiating cell, by conferring
epidermal basal cells with a primordial HF-like fate.
MATERIALS AND METHODS
Mouse strains
K14CreERT2 mice (Li et al., 2000), K14Cre mice (Jonker et al., 2004),
K5Cre mice (Tarutani et al., 1997), Ptch1lox mice (Ellis et al., 2003),
and Ptch2tm1 mice (Nieuwenhuis et al., 2006) have been previously
described. K5Cre, Ptch1, Ptch1;Ptch2 strains, and K5Cre:Ptch1 and
K5Cre:Ptch1;Ptch2 embryos were all maintained in the Hui
laboratory on a mixed outbred background of CD1, and 129/Sv.
K14Cre, Ptch1 strains and K14Cre:Ptch1 and K14Cre:Ptch1;Ptch2
embryos were all maintained in the Wainwright laboratory on mixed
genetic backgrounds. Despite the mixed genetic backgrounds of all
mice, we observe no phenotype/genotype variation. The phenotypes
have been completely consistent across this study. All animal studies
were reviewed and approved by the University of Queensland animal
ethics committee.
During our analyses of the phenotypes described within this
manuscript, we always observed Ptch1 heterozygote and Ptch2-
deficient embryos to be indistinguishable from wild-type embryos.
‘‘Control’’ animals therefore refer to either wild-type, Ptch1 hetero-
zygote, and Ptch2-deficient embryos.
Immunohistochemistry, in situ hybridization, and alkaline
phosphatase analysis
Flank skin specimens from E14.5 to E18.5 embryos were fixed
overnight in 4% paraformaldehyde in phosphate-buffered saline and
embedded in paraffin. Histological analysis and antibody markers
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were analyzed on 4-mm tissue sections via standard immunofluores-
cence and immunohistochemistry techniques using the following
antibodies: K14, K5, K10, loricrin (Covance, Princeton, NJ), Ki67
(DAKO, Agilent Technologies, Santa Clara, CA), PCNA (Invitrogen,
Carlsbad, CA and Santa Cruz Biotechnologies, Santa Cruz, CA), p63,
CDP (Santa Cruz), Lef1 (Cell Signalling Technologies, Danvers MA),
Sox9 (R&D Systems, Minneapolis, MN), p-cadherin (Life Technolo-
gies, Carlsbad, CA), and cyclinD1 (Abcam, Cambridge, UK). In situ
hybridization and alkaline phosphatase analysis were performed on
5-mm paraffin sections as previously described (Li et al., 2012).
TM treatment
Mice aged between 6–8 weeks were anesthetized with isoflourane,
and a patch of skin was shaved from both their left and right flanks.
The right flank was treated with vehicle (acetone) alone. Left flank
was treated with 500mg of TM. Treatment was performed for 2 days.
Four-weeks post-treatment skin was collected and processed for
histology.
Skin grafts
E18.5 epidermis was grafted onto severe combined immunodefi-
ciency mice as previously described (Adolphe et al., 2004)
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